GFA
8783
Chiome Bioscience
4583
Pluszero
5132
Pixel
2743
GreenBee
3913
(Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -18.43%149.95B | -141.43%-81.26B | -64.90%747.28B | -21.79%325.56B | -88.75%41.77B | -74.58%183.83B | -68.27%196.12B | 26.76%2.13T | -43.12%416.27B | -42.83%371.42B |
Net income from continuing operations | -49.92%182.48B | 8.65%559.47B | 86.73%1.64T | 1,771.71%377.86B | 12.14%385.24B | 30.86%364.36B | 116.90%514.92B | -17.81%879.57B | -91.03%20.19B | 20.61%343.55B |
Operating gains losses | 192.97%22.19B | 96.65%-1.43B | 5.64%-110.82B | -238.51%-43.55B | 99.18%-543M | 60.44%-23.87B | -89.54%-42.85B | 42.01%-117.45B | 169.14%31.44B | -32.44%-65.94B |
Depreciation and amortization | -4.89%178.88B | 1.20%187.93B | 10.08%794.37B | 3.39%191B | 27.85%229.59B | -3.98%188.08B | 15.03%185.7B | 18.09%721.63B | 20.69%184.74B | 19.72%179.59B |
Other non cashItems | 78.11%-30.42B | -8.49%-78.88B | -55.70%-341.51B | -118.03%-83.75B | -23.89%-46.11B | -84.06%-138.95B | -6.57%-72.71B | 5.46%-219.34B | 38.41%-38.41B | 40.31%-37.22B |
Change In working capital | 27.48%-130.93B | -62.88%-722.24B | -232.25%-1.13T | -116.46%-26.18B | -938.30%-481.71B | -140.00%-180.53B | -251.93%-443.42B | 182.81%855.84B | -64.09%159.07B | -114.56%-46.39B |
-Change in receivables | 69.25%-154.19B | 11.82%-178.73B | -706.81%-1.59T | 22.70%-351.06B | -587.70%-537.57B | -735.46%-501.36B | -179.18%-202.7B | -140.64%-197.4B | -813.31%-454.14B | -157.42%-78.17B |
-Change in inventory | 32.73%-20.22B | -472.42%-108.55B | 60.44%-67.83B | 116.09%8.58B | -750.61%-75.51B | 71.83%-30.05B | 226.51%29.15B | 17.92%-171.47B | -559.30%-53.34B | 219.46%11.61B |
-Change in payables and accrued expense | 10.64%156.26B | -10.72%-251.99B | 31.69%194.1B | -20.72%245.78B | 168.64%34.67B | 22.83%141.24B | -0.21%-227.59B | 888.67%147.39B | 75.22%310.04B | -132.87%-50.51B |
-Change in other current assets | -462.84%-183.4B | -270.35%-76.75B | -98.35%12.66B | -158.32%-66.83B | -110.09%-16.11B | -78.01%50.54B | -82.93%45.05B | 347.59%768.07B | -32.99%114.58B | 57.06%159.71B |
-Change in other working capital | -55.62%70.61B | -21.63%-106.23B | 4.10%321.92B | -43.23%137.34B | 226.70%112.81B | 18.49%159.1B | -495.59%-87.33B | 343.32%309.25B | 512.94%241.93B | -16.52%-89.04B |
Dividends received (cash flow from operating activities) | -66.55%30.21B | 40.44%51.02B | -35.45%158.09B | -85.53%14.15B | 11.56%17.31B | -13.06%90.3B | 31.11%36.33B | 26.53%244.9B | 17.13%97.81B | 74.17%15.52B |
Interest paid (cash flow from operating activities) | -67.94%-113.96B | -131.46%-99.21B | -78.25%-283.45B | -80.83%-101.5B | -105.95%-71.23B | -47.81%-67.86B | -91.38%-42.86B | -62.46%-159.02B | -96.34%-56.13B | -45.08%-34.59B |
Interest received (cash flow from operating activities) | 28.65%181.25B | 57.28%181.05B | 72.93%560.71B | 64.33%153.8B | 73.66%150.91B | 83.13%140.88B | 72.30%115.12B | 36.39%324.23B | 59.85%93.59B | 44.27%86.9B |
Tax refund paid | 9.99%-169.75B | -193.82%-158.98B | -34.71%-540.66B | -105.54%-156.28B | -102.45%-141.7B | 6.39%-188.58B | -0.46%-54.11B | -97.58%-401.34B | 19.80%-76.03B | -89.28%-69.99B |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -18.43%149.95B | -141.43%-81.26B | -64.90%747.28B | -21.79%325.56B | -88.75%41.77B | -74.58%183.83B | -68.27%196.12B | 26.76%2.13T | -43.12%416.27B | -42.83%371.42B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -100.87%-326.51B | -52.15%-192.6B | -27.90%-867.27B | -248.99%-325.85B | -61.69%-252.3B | -8.10%-162.54B | 54.51%-126.58B | -80.31%-678.06B | -1,731.47%-93.37B | -0.63%-156.04B |
Net PPE purchase and sale | -17.24%-81.24B | -104.42%-138.75B | 27.15%-334.26B | -26.92%-110.2B | 36.21%-86.89B | 51.65%-69.29B | 26.62%-67.88B | -90.36%-458.84B | -48.86%-86.83B | -180.74%-136.21B |
Net intangibles purchas and sale | -33.54%-73.95B | -62.90%-68.62B | -65.13%-259.99B | -162.36%-96.36B | -49.35%-66.12B | -46.73%-55.38B | -8.85%-42.13B | 13.06%-157.44B | 32.62%-36.73B | 1.46%-44.27B |
Net business purchase and sale | -2,417.90%-50.36B | 97.91%-831M | -733.02%-192.31B | -531.48%-80.49B | ---70.15B | 80.66%-2B | ---39.67B | ---23.09B | ---12.75B | --0 |
Net investment purchase and sale | -237.15%-120.96B | -32.43%15.6B | -108.59%-80.71B | -190.34%-38.79B | -219.19%-29.14B | -187.47%-35.88B | 115.70%23.09B | -184.00%-38.69B | -63.78%42.94B | 139.67%24.44B |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -100.87%-326.51B | -52.15%-192.6B | -27.90%-867.27B | -248.99%-325.85B | -61.69%-252.3B | -8.10%-162.54B | 54.51%-126.58B | -80.31%-678.06B | -1,731.47%-93.37B | -0.63%-156.04B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -8.60%235.65B | 655.02%81.95B | 162.56%918.65B | 378.15%415.97B | 170.93%259.63B | 175.07%257.81B | 97.58%-14.77B | -138.48%-1.47T | -295.69%-149.55B | 23.65%-366.05B |
Net issuance payments of debt | 28.05%471.03B | 85.71%306.33B | 242.71%1.49T | 762.66%473.84B | 344.45%487.35B | 229.03%367.85B | 133.60%164.95B | -236.27%-1.05T | -180.91%-71.51B | 40.92%-199.36B |
Net common stock issuance | -148.19%-212.21B | 79.39%-12.18B | -59.63%-250.01B | 44.03%-37.43B | -11.41%-67.96B | -194.81%-85.5B | -22,748.66%-59.11B | -151.88%-156.62B | -50,010.45%-66.88B | -40.92%-61B |
Cash dividends paid | --0 | -88.58%-188.42B | -13.30%-241.87B | --0 | -38.87%-141.95B | --0 | 10.19%-99.92B | -13.31%-213.48B | --0 | -7.45%-102.22B |
Net other financing activities | 5.59%-23.17B | -14.93%-23.78B | -62.46%-83.47B | -83.04%-20.43B | -414.36%-17.81B | 16.31%-24.54B | -178.40%-20.69B | 4.53%-51.38B | 7.68%-11.16B | 2.89%-3.46B |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -8.60%235.65B | 655.02%81.95B | 162.56%918.65B | 378.15%415.97B | 170.93%259.63B | 175.07%257.81B | 97.58%-14.77B | -138.48%-1.47T | -295.69%-149.55B | 23.65%-366.05B |
Net cash flow | ||||||||||
Beginning cash position | 21.89%4.98T | 30.28%4.95T | 3.49%3.8T | 20.84%4.34T | 12.84%4.44T | 12.49%4.08T | 3.49%3.8T | 33.25%3.67T | 33.62%3.6T | 50.25%3.94T |
Current changes in cash | -78.82%59.1B | -450.38%-191.92B | 4,690.77%798.66B | 139.79%415.68B | 132.59%49.1B | 21.65%279.1B | 120.32%54.77B | -102.53%-17.4B | -78.70%173.35B | -1,090.94%-150.66B |
Effect of exchange rate changes | -630.73%-414.08B | -4.87%214.61B | 142.57%352.89B | 462.24%194.41B | 23.45%-145.14B | 2.92%78.02B | 0.40%225.61B | -36.49%145.48B | -79.72%34.58B | -438.75%-189.6B |
End cash Position | 4.09%4.62T | 21.89%4.98T | 30.28%4.95T | 30.28%4.95T | 20.84%4.34T | 12.84%4.44T | 12.49%4.08T | 3.49%3.8T | 3.49%3.8T | 33.62%3.6T |
Free cash from | -112.89%-7.25B | -440.47%-288.68B | -90.74%138.61B | -62.36%109.62B | -159.03%-112.06B | -89.45%56.26B | -82.43%84.79B | 21.63%1.5T | -52.09%291.24B | -65.28%189.82B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |